Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancers|July 15, 2026
Radiotherapy-Associated Systemic Antitumor Responses Beyond the Classical Abscopal ParadigmYosuke Dotsu, Kazumasa Akagi, Noritaka Honda, et al.
Tropical Medicine and Health|October 26, 2012
Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic JapanMasashi Otani, Noritaka Honda, Pin-Cang Xia, et al.
Frontiers in Oncology|December 25, 2025
Acute amivantamab-induced myocardial injury in a patient with epidermal growth factor receptor-mutant lung cancer: a first case reportSeiya Kaneko, Yosuke Dotsu, Tomoaki Inoue, et al.
Discover Oncology|January 15, 2026
Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitorNoritaka Honda, Hirokazu Taniguchi, Sawana Ono, et al.
Translational Lung Cancer Research|July 11, 2026
Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: a case reportToru Morikawa, Yosuke Dotsu, Kenta Torigoe, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Regression of a Non-Irradiated Lung Adenocarcinoma During Glioblastoma-Directed Chemoradiotherapy: A Case ReportMizuki Iwanaga, Yosuke Dotsu, Takeshi Hiu, et al.
Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.
Pageof 2